MedPath

Cristália Produtos Químicos Farmacêuticos Ltda.

🇧🇷Brazil
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.2cristalia.com.br

Clinical Trials

14

Active:1
Completed:2

Trial Phases

4 Phases

Early Phase 1:1
Phase 2:1
Phase 3:8
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials

Phase 3
8 (61.5%)
Phase 4
3 (23.1%)
Early Phase 1
1 (7.7%)
Phase 2
1 (7.7%)

Safety of CRIS100 on Treatment Spinal Cord Injury

Early Phase 1
Not yet recruiting
Conditions
Thoracic Spinal Cord Injury
Interventions
First Posted Date
2023-02-22
Last Posted Date
2023-02-22
Lead Sponsor
Cristália Produtos Químicos Farmacêuticos Ltda.
Target Recruit Count
5
Registration Number
NCT05739734

Hyperbaric Novabupi® in Spinal Anesthesia in Lower Limbs Vascular Surgery

Phase 3
Conditions
Spinal Anesthesia
Vascular Surgery
First Posted Date
2019-03-21
Last Posted Date
2023-02-08
Lead Sponsor
Cristália Produtos Químicos Farmacêuticos Ltda.
Target Recruit Count
120
Registration Number
NCT03883763
Locations
🇧🇷

CEPEC, São Luís, Maranhão, Brazil

Esmolol for the Treatment of Hypertension After Intracerebral Hemorrhage Study (ETHICHS)

Phase 4
Terminated
Conditions
Hemorrhagic Stroke
Interventions
Drug: Brevibloc, 10 Mg/mL Intravenous Solution
Drug: Nitroprusside, Sodium
First Posted Date
2018-11-15
Last Posted Date
2023-02-09
Lead Sponsor
Cristália Produtos Químicos Farmacêuticos Ltda.
Target Recruit Count
20
Registration Number
NCT03743103
Locations
🇧🇷

Hospital São Rafael, Salvador, Bahia, Brazil

🇧🇷

Hospital Geral de Fortaleza, Fortaleza, Ceará, Brazil

🇧🇷

Hospital Madre Teresa, Belo Horizonte, Minas Gerais, Brazil

and more 4 locations

Evaluate the Efficacy of Oxybutynin Chloride in Patients With Primary Hyperhidrosis

Phase 3
Withdrawn
Conditions
Hyperhidrosis
Interventions
Drug: Placebo
First Posted Date
2014-03-31
Last Posted Date
2016-07-26
Lead Sponsor
Cristália Produtos Químicos Farmacêuticos Ltda.
Registration Number
NCT02099695
Locations
🇧🇷

Hospital Israelita Albert Einstein, São Paulo, Brazil

🇧🇷

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

Evaluate the Noninferiority of Medicines Treating Uninfected Pressure Ulcers.

Phase 3
Withdrawn
Conditions
Pressure Ulcer
Interventions
Drug: Kollagenase
First Posted Date
2013-12-09
Last Posted Date
2015-07-16
Lead Sponsor
Cristália Produtos Químicos Farmacêuticos Ltda.
Registration Number
NCT02004626
Locations
🇧🇷

Clínica Dr. Norton Sayeg Ltda, São Paulo, Brazil

  • Prev
  • 1
  • 2
  • 3
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.